Innovative First-in-Man trials and early phase studies

Session comprising selected EuroPCR 2019 Late-Breaking Trial submissions

Chairpersons: J. Granada, F. Mahfoud

Panellists: J. Bartunek, C. Lotan

Summary

Consult this session to learn more about innovative First-in-Man trials and early phase studies regarding hypertension, chronic heart failure and renal denervation, such as: TROPHY1, Cryo-RDN, AFR-Prelieve, and more!

Presentations available when logged in:

Percutaneous therapeutic IVUS pulmonary artery denervation for the treatment of pulmonary arterial hypertension (TROPHY1): a multicentre, internati...
Comparison of radiofrequency ablation vs. cryodenervation in patients with pre-capillary pulmonary hypertension
Validation of a novel catheter-based renal denervation system of cryoablation (Cryo-RDN) in patients with resistant hypertension: a first-in-man study
Renal denervation prevents atrial fibrillation and reduces cardiovascular death in patients with hypertensive heart disease
NOGA-guided intramyocardial CERA injections
Early transendocardial injection of autologous bone marrow-derived mononuclear cells following ischaemic myocardial events: the Alster-Helix registry
The AFR-Prelieve trial: Atrial Flow Regulator in Heart Failure Patients

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Innovative First-in-Man trials and early phase studies

Session comprising selected EuroPCR 2019 Late-Breaking Trial submissions

Log in or create account for free